| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9872508 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 7 Pages |
Abstract
Conclusions: Abdominopelvic radiotherapy after optimal surgery and carboplatin/paclitaxel chemotherapy is associated with an acceptable risk of acute and late side effects and does not limit subsequent salvage chemotherapy. Consolidative APRT warrants further investigation as a means of improving the outcome of patients with ovarian cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Robert M.D., Michael M.D., Melania M.Sc., Anthony M.D., Stephane M.D., Denny M.D., Wilfred M.D., Lee M.D., Joan M.D., Amit M.D., Barry M.D., Jeremy M.D., Michael M.D.,